BASF and trinamiX to Present Textile Circularity Solutions

BASF SE BASFY is set to showcase its textile sorting and circularity solutions in collaboration with trinamiX GmbH, its subsidiary and provider of mobile spectroscopy solutions. The event will take place in Brussels, Belgium, from June 4 to June 5.The platform will be used to demonstrate textile circularity from reliable material identification to the use of recycled polyamide 6 for high-performance textiles. BASFY will display its recycled polyamide 6 product, loopamid. Based entirely on textile waste, loopamid allows textile-to-textile recycling for polyamide 6 in a range of fabric blends. BASF recently announced the start-up of the world’s first commercial loopamid facility in Shanghai, China. The plant uses industrial textile waste from textile manufacturing and post-consumer waste for making loopamid and its feedstock includes cutting scraps, defective cuts, offcuts and other production textile waste from the textile industry.trinamiX Mobile Near-Infrared (“NIR”) Spectroscopy Solution will also be exhibited. This enables fast, reliable and non-destructive identification of a wide range of textiles and blends. The system is installed with a robust, portable NIR spectrometer, accompanied by an app that leverages sophisticated cloud-based data analysis, along with a customer portal for managing results, downloading reports and exporting data. The subsidiary will also present trinamiX PAL Two, the latest generation of its handheld spectrometer made for convenient, single-handed operation. Joint presence of BASF and trinamiX will highlight such textile sorting, recycling and circular solutions.BASFY stock has lost 6.9% over the past year compared with the industry’s 27.1% decline.Image Source: Zacks Investment ResearchBASFY’s Zacks Rank & Key PicksBASFY currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. AKZOY, Newmont Corporation NEM and Balchem Corporation BCPC. While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have gained 29.4% in the past year.The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 9.7% in the past year.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Newmont Corporation (NEM): Free Stock Analysis Report BASF SE (BASFY): Free Stock Analysis Report Akzo Nobel NV (AKZOY): Free Stock Analysis Report Balchem Corporation (BCPC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks